Nu Skin Enterprises, Inc.
Description
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
About
CEO
Mr. Ryan S. Napierski
Employees
3,700
Instrument type
Common Stock
Sector
Consumer Defensive
Industry
Household & Personal Products
MIC code
XNYS
Address
75 West Center Street, Provo, UT 84601, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 6, 2025 | — | — | — | — |
| Aug 7, 2025 | — | — | — | — |
| May 6, 2025 | — | — | — | — |
| Feb 13, 2025 | 0.24 | — | — | — |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 3 | — | 3 |
| Average estimate | — | 0.15 | — | 0.84 |
| Low estimate | — | 0.05 | — | 0.46 |
| High estimate | — | 0.27 | — | 1.06 |
| Last year EPS | — | 0.09 | — | 0.68 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-40.390%
Next qtr. (Mar 2025)
65.840%
Current year
-63.500%
Next year (Dec 2025)
24.690%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 1.97B | 2.23B | 2.70B | 2.58B | 2.42B |
| Cost of revenue | 611.85M | 630.92M | 675.22M | 658.03M | 581.42M |
| Gross profit | 1.36B | 1.59B | 2.02B | 1.92B | 1.84B |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 1.29B | 1.44B | 1.73B | 1.67B | 1.57B |
| Other operating expenses | — | — | — | — | — |
| Operating income | 68.06M | 159.34M | 285.86M | 257.56M | 267.43M |
| Non operating interest income | |||||
| Income | — | — | — | — | — |
| Expense | — | — | — | — | — |
| Other income expense | -41.48M | -70.37M | -53.40M | -1.33M | -12.25M |
| Pretax income | 26.58M | 88.97M | 232.46M | 256.23M | 255.17M |
| Tax provision | 17.98M | -15.81M | 85.19M | 64.88M | 81.62M |
| Net income | 8.60M | 104.78M | 147.27M | 191.36M | 173.55M |
| Basic EPS | 0.17 | 2.10 | 2.93 | 3.66 | 3.13 |
| Diluted EPS | 0.17 | 2.07 | 2.86 | 3.63 | 3.10 |
| Basic average shares | 49.71M | 50.00M | 50.19M | 52.30M | 55.52M |
| Diluted average shares | 49.71M | 50.00M | 50.19M | 52.30M | 55.52M |
| EBITDA | 158.77M | 280.34M | 414.05M | 331.56M | 344.08M |
| Net income from continuing op. | 8.60M | 104.78M | 147.27M | 191.36M | 173.55M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 1.81B | 1.82B | 1.91B | 1.96B | 1.77B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 256.06M | 264.73M | 339.59M | 402.68M | 335.63M |
| Other short term investments | 11.76M | 13.78M | 15.22M | 21.22M | 8.41M |
| Accounts receivable | 72.88M | 47.36M | 41.30M | 63.37M | 50.38M |
| Other receivables | — | — | — | — | — |
| Inventory | 279.98M | 346.18M | 399.93M | 314.37M | 275.89M |
| Prepaid assets | 44.10M | 48.48M | 44.48M | 76.29M | 45.35M |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | 8.96M | 9.16M | 557,000 | — | — |
| Other current assets | 17.92M | 18.43M | 17.61M | 14.73M | 16.37M |
| Non current assets | |||||
| Properties | 101.28M | 112.99M | 127.45M | 164.49M | 144.33M |
| Land and improvements | 42.25M | 42.93M | 45.03M | 45.24M | 44.53M |
| Machinery furniture equipment | 322.04M | 290.81M | 319.30M | 294.56M | 288.52M |
| Construction in progress | 25.48M | 78.44M | 61.14M | 55.74M | 64.60M |
| Leases | 99.93M | 114.63M | 129.68M | 164.96M | 160.62M |
| Accumulated depreciation | -354.70M | -342.19M | -365.54M | -350.32M | -331.04M |
| Goodwill | 566.85M | 479.57M | 489.86M | 495.49M | 473.47M |
| Investment properties | — | — | — | — | — |
| Financial assets | 3.73M | 10.58M | 6.03M | — | — |
| Intangible assets | 105.31M | 66.70M | 76.99M | 89.53M | 80.32M |
| Investments and advances | 36.37M | 39.49M | 35.87M | 11.34M | — |
| Other non current assets | 185.49M | 166.22M | 109.96M | 96.57M | 107.12M |
| Total liabilities | 984.50M | 923.67M | 993.71M | 1.06B | 893.72M |
| Current liabilities | |||||
| Accounts payable | 43.51M | 53.96M | 49.99M | 66.17M | 38.98M |
| Accrued expenses | 183.80M | 198.67M | 270.99M | 303.73M | 197.21M |
| Short term debt | 48.90M | 54.38M | 140.93M | 74.98M | 66.85M |
| Deferred revenue | 20.39M | 27.05M | 33.14M | 35.05M | 20.16M |
| Tax payable | 21.25M | 21.82M | 31.14M | 58.94M | 29.66M |
| Pensions | — | — | — | — | — |
| Other current liabilities | 6.30M | — | — | — | — |
| Non current liabilities | |||||
| Long term debt | 558.43M | 466.15M | 362.86M | 425.40M | 440.16M |
| Provision for risks and charges | — | — | — | — | 17.12M |
| Deferred liabilities | 35.54M | 35.97M | 24.16M | 23.36M | 27.86M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 8.95M | 11.91M | 17.38M | 16.94M | 15.61M |
| Shareholders equity | |||||
| Common stock | 91,000 | 91,000 | 91,000 | 91,000 | 91,000 |
| Retained earnings | 1.87B | 1.94B | 1.91B | 1.84B | 1.73B |
| Other shareholders equity | -100.01M | -86.51M | -73.90M | -64.77M | -85.29M |
| Total shareholders equity | 821.97M | 897.30M | 912.77M | 894.27M | 875.29M |
| Additional paid in capital | 621.85M | 613.28M | 601.70M | 579.80M | 557.54M |
| Treasury stock | 1.57B | 1.57B | 1.53B | 1.46B | 1.32B |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||
| Net Income | 8.60M | 104.78M | 147.27M | 191.36M | 173.55M | 121.89M | 129.44M | 143.09M | 133.05M | 189.18M | 364.89M | 221.65M | 153.33M | 136.05M | 89.85M | 65.35M | 43.87M | 32.82M | 74.03M | 77.67M | 67.88M | 64.84M | 50.31M | 61.70M | 86.70M | 103.90M | 118.50M | 84.70M | 40.20M |
| Depreciation | 70.92M | 72.51M | 76.32M | 73.99M | 76.65M | 83.00M | 71.56M | 72.40M | 71.37M | 54.92M | 34.92M | 33.41M | 32.85M | 29.62M | 28.56M | 30.39M | 32.97M | 29.13M | 31.37M | 28.66M | 23.08M | 21.60M | 32.43M | 37.60M | 33.20M | 41.00M | 32.00M | 12.10M | 2.00M |
| Deferred Taxes | -18.09M | -51.63M | 5.82M | -11.91M | 1.97M | -14.93M | 39.21M | -17.65M | 17.36M | 10.40M | -41.75M | 4.69M | 108,000 | -13.74M | 12.35M | -4.08M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | 15.65M | 12.37M | 23.19M | 24.06M | 9.91M | 26.61M | 19.31M | 8.89M | 7.40M | 17.50M | 32.62M | 21.36M | 15.45M | 10.84M | 9.99M | 7.27M | 8.13M | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | 33.32M | 44.52M | 48.70M | 46.16M | 44.46M | -13.64M | — | 31.36M | — | — | — | — | 32.75M | — | — | — | 8.13M | 28.29M | — | — | — | — | — | — | 100,000 | 100,000 | 100,000 | 100,000 | — |
| Accounts Receivable | -22.68M | -11.45M | 20.22M | -11.21M | 2.75M | -10.45M | -103,000 | 3.36M | -2.25M | 30.77M | -34.30M | -7.88M | -5.89M | -6.65M | -7.04M | 7.07M | -2.65M | -2.79M | -626,000 | -1.00M | 3.86M | 6.38M | -912,000 | 3.22M | -8.20M | 300,000 | -3.30M | -10.00M | 13.90M |
| Accounts Payable | -10.08M | 9.26M | -13.28M | 24.84M | -7.18M | -9.16M | 6.83M | 13.44M | -4.30M | -45.95M | 32.64M | 15.83M | 6.08M | -568,000 | 3.60M | -6.14M | 2.96M | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | -17.58M | -15.70M | -142.00M | -65.59M | -65.58M | -53.23M | -301,000 | 4.92M | 25.89M | -49.00M | -239.65M | -45.20M | -25.34M | 26.34M | -6.14M | -15.98M | -32.00M | -3.48M | -1.76M | -3.22M | 1.14M | 20.04M | -3.09M | -52.28M | -85.60M | -34.60M | -56.90M | 43.50M | 8.10M |
| Operating Cash Flow | 60.05M | 164.66M | 166.25M | 271.69M | 236.52M | 130.08M | 265.96M | 259.79M | 248.52M | 207.81M | 149.37M | 243.86M | 209.34M | 181.89M | 131.16M | 83.89M | 61.41M | 83.97M | 103.02M | 102.12M | 95.96M | 112.86M | 78.74M | 50.24M | 26.20M | 110.70M | 90.40M | 130.40M | 64.20M |
| Investing Activities | |||||||||||||||||||||||||||||
| Capital Expenditures | -58.49M | -59.06M | -68.62M | -63.82M | -66.07M | -70.37M | -60.16M | -50.22M | -56.62M | -101.48M | -185.10M | -96.65M | -41.81M | -53.78M | -20.22M | -16.01M | -22.74M | -37.66M | -30.88M | -35.00M | -23.52M | -19.03M | -15.13M | -23.03M | -43.30M | -47.10M | -14.40M | -9.20M | -5.40M |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | -77.28M | — | -18.96M | -14.95M | -8.07M | -38.51M | -31.75M | -8.69M | — | — | — | -12.56M | -11.66M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Purchase of Investments | -16.88M | -13.96M | -16.24M | -14.69M | -8.43M | -11.42M | -11.33M | -17.08M | -15.75M | -17.52M | -21.67M | -15.74M | -24.36M | — | — | -13.91M | -136.75M | -173.93M | -160.38M | -198.20M | — | — | — | — | — | — | — | — | — |
| Sale of Investments | 18.15M | 5.93M | 15.09M | 14.04M | 11.16M | 11.54M | 11.27M | 18.13M | 11.53M | 27.33M | 13.08M | 20.09M | 6.63M | — | — | 19.14M | 131.53M | 173.93M | 170.61M | 185.02M | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | -134.50M | -67.08M | -88.73M | -79.43M | -71.41M | -108.76M | -91.96M | -57.86M | -60.85M | -91.67M | -193.70M | -104.86M | -71.20M | -53.78M | -20.22M | -10.78M | -27.96M | -37.66M | -26.20M | -48.18M | -23.52M | -26.53M | -15.13M | -22.97M | -44.00M | -46.10M | -17.70M | -9.60M | -6.10M |
| Financing Activities | |||||||||||||||||||||||||||||
| Long-Term Debt Issuance | 110.00M | 460.00M | 155.00M | 115.00M | 145.00M | 582.40M | 67.00M | 233.72M | 36.22M | 416.18M | 49.00M | 101.92M | — | 30.00M | — | — | 64.85M | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | -13.20M | -434.42M | -116.87M | -143.21M | -214.46M | -552.50M | -103.23M | -56.15M | -35.51M | -333.80M | -37.90M | -28.28M | -28.00M | -37.40M | -30.19M | -32.71M | -31.73M | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Financing Charges | — | -5.08M | — | — | — | -7.24M | — | -945,000 | 5.34M | 6.06M | 45.19M | 7.75M | -4.94M | 6.91M | 1.10M | — | 1.77M | 1.84M | — | — | — | — | — | — | -35.00M | -100,000 | 11.40M | 1.60M | 3.30M |
| Financing Cash Flow | 6.17M | -126.56M | -118.56M | -250.93M | -152.47M | -127.49M | -184.02M | -149.02M | -239.24M | -38.66M | -155.10M | -168.45M | -136.72M | -90.20M | -79.24M | -66.75M | -57.63M | -88.01M | -43.87M | -78.31M | -162.97M | -18.33M | -33.77M | -12.47M | -59.00M | -8.60M | -39.40M | 20.40M | -8.90M |
| Other Cash Details | |||||||||||||||||||||||||||||
| End Cash Position | 256.06M | 264.73M | 339.59M | 402.68M | 335.63M | 386.91M | 426.40M | 357.25M | 289.35M | 288.42M | 525.15M | 320.03M | 272.97M | 230.34M | 158.05M | 114.59M | 87.33M | 121.35M | 155.41M | 109.87M | 122.57M | 120.34M | 75.92M | 64.00M | 110.20M | — | 174.30M | — | — |
| Income Tax Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 60.15M | 49.01M | 72.97M | 315.32M | 111.86M | 132.37M | 242.40M | 225.04M | 265.49M | -157.94M | 345.07M | 214.33M | 182.51M | 134.10M | 113.73M | 87.30M | 25.92M | 38.13M | 83.22M | 95.35M | 85.51M | 92.09M | 59.29M | 20.36M | -13.00M | 71.50M | 94.20M | 133.20M | 59.60M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 1,631,724 | 10.51M | 3.28% |
| iShares Russell 2000 ETF | Nov 30, 2024 | 1,447,890 | 9.32M | 2.91% |
| Federated Hermes MDT Small Cap Core Fund | Oct 31, 2024 | 817,961 | 5.27M | 1.65% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 809,977 | 5.22M | 1.63% |
| Avantis U.S. Small Cap Value ETF | Nov 30, 2024 | 632,345 | 4.07M | 1.27% |
| Vanguard Small-Cap Index Fund | Sep 30, 2024 | 591,517 | 3.81M | 1.19% |
| Vanguard Consumer Staples Index Fund | Nov 30, 2024 | 545,462 | 3.51M | 1.10% |
| iShares Russell 2000 Value ETF | Nov 30, 2024 | 504,178 | 3.25M | 1.01% |
| Fidelity Small Cap Index Fund | Oct 31, 2024 | 494,745 | 3.19M | 1.00% |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | Nov 30, 2024 | 436,213 | 2.81M | 0.88% |
Article
Nu Skin Gears Up for Q4 Earnings: What Surprise Awaits Investors?
NUS' fourth-quarter 2024 results are likely to show the impacts of a tough operating backdrop and pressures within the direct selling industry.
Feb 10, 2025
Article
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Feb 6, 2025
Article
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8%
Nu Skin's shares rally as the company stated that its preliminary revenues for Q4 came in at the upper end of its projected range.
Jan 14, 2025
